This CrowdStrike Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday

Alector
CrowdStrike
Dianthus Therapeutics, Inc.
Rivian Automotive
SolarEdge Technologies, Inc.

Alector

ALEC

0.00

CrowdStrike

CRWD

0.00

Dianthus Therapeutics, Inc.

DNTH

0.00

Rivian Automotive

RIVN

0.00

SolarEdge Technologies, Inc.

SEDG

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Morgan Stanley analyst Keith Weiss upgraded CrowdStrike Holdings (NASDAQ:CRWD) from Equal-Weight to Overweight and raised the price target from $487 to $510. CrowdStrike shares closed at $434.13 on Monday. See how other analysts view this stock.
  • BTIG analyst Thomas Shrader upgraded Alector Inc (NASDAQ:ALEC) from Neutral to Buy and announced a $6 price target. Alector shares closed at $2.19 on Monday. See how other analysts view this stock.
  • TD Cowen analyst Itay Michaeli upgraded Rivian Automotive Inc (NASDAQ:RIVN) from Hold to Buy and raised the price target from $17 to $20. Rivian Automotive shares closed at $15.87 on Monday. See how other analysts view this stock.
  • B of A Securities analyst Julien Dumoulin-Smith upgraded Solaredge Technologies Inc (NASDAQ:SEDG) from Underperform to Neutral and raised the price target from $17 to $40. SolarEdge shares closed at $34.59 on Monday. See how other analysts view this stock.
  • Raymond James analyst Steven Seedhouse upgraded Dianthus Therapeutics Inc (NASDAQ:DNTH) from Outperform to Strong Buy and raised the price target from $63 to $123. Dianthus Therapeutics shares closed at $79.23 on Monday. See how other analysts view this stock.

Considering buying CRWD stock? Here’s what analysts think:

Photo via Shutterstock